Investors aiming for above-average returns often turn to the practice of stock picking. Skillful choices in individual stocks can be a catalyst for substantial wealth growth.
In the latest session, Allogene Therapeutics Inc (NASDAQ: ALLO) closed at $1.84 up 1.10% from its previous closing price of $1.82. In other words, the price has increased by $1.10 from its previous closing price. On the day, 3.2 million shares were traded. ALLO stock price reached its highest trading level at $1.905 during the session, while it also had its lowest trading level at $1.78.
Ratios:
For a deeper understanding of Allogene Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.35 and its Current Ratio is at 9.35. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.18.
On May 31, 2024, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $11.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jan 21 ’25 when Roberts Zachary bought 27,199 shares for $1.78 per share.
MESSEMER DEBORAH M. sold 9,136 shares of ALLO for $19,916 on Dec 09 ’24. The Director now owns 157,629 shares after completing the transaction at $2.18 per share. On Dec 05 ’24, another insider, Humer Franz B, who serves as the Director of the company, sold 9,221 shares for $2.16 each. As a result, the insider received 19,917 and left with 307,507 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLO now has a Market Capitalization of 385796480 and an Enterprise Value of 186756640. For the stock, the TTM Price-to-Sale (P/S) ratio is 9644.84 while its Price-to-Book (P/B) ratio in mrq is 0.83. Its current Enterprise Value per Revenue stands at 4343.178 whereas that against EBITDA is -0.732.
Stock Price History:
Over the past 52 weeks, ALLO has reached a high of $5.78, while it has fallen to a 52-week low of $1.78. The 50-Day Moving Average of the stock is -17.96%, while the 200-Day Moving Average is calculated to be -30.07%.
Shares Statistics:
For the past three months, ALLO has traded an average of 2.69M shares per day and 3077940 over the past ten days. A total of 209.50M shares are outstanding, with a floating share count of 142.63M. Insiders hold about 31.97% of the company’s shares, while institutions hold 68.29% stake in the company. Shares short for ALLO as of 1735603200 were 30906822 with a Short Ratio of 11.49, compared to 1732838400 on 31167763. Therefore, it implies a Short% of Shares Outstanding of 30906822 and a Short% of Float of 20.729999.
